EUnetHTA has published a document describing the process regarding direct patient input in REAs within JA3.
According to EUnetHTA, the document is primarily intended for those who design and conduct EUnetHTA relative effectiveness assessments (REAs), and discusses preferred ways to implement patient input while protecting confidentiality and avoiding conflicts of interest.
The document describes how the goals of obtaining patient input in REAs are :
- to collect patient input regarding:
- their disease/condition and their unmet needs
- currently available treatments
- expectations with respect to new treatments (e.g. fewer side effects)
- identification of subgroups and possible effect modifiers
- quality of life issues
- target treatment population and risks of off-label use
- gather information about outcomes that are important and relevant from a patient’s point of view
Read more from the EUnetHTA document on patient input in REAs here.